Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
MSCI Upgrades Argentina To Emerging Market Status

2018-07-01 seekingalpha
On Thursday, June 21st, MSCI announced the MSCI Argentina Index will be reclassified to Emerging Market status from Frontier Market status.1 This change is set to take effect in May 2019, with Argentina expected to represent approximately 0.4% in the MSCI Emerging Markets Index. While Argentina’s most recent economic woes demonstrate its prospective challenges, international consensus remains sufficiently confident in Argentina’s long-term commitments to boosting market access and facilitating international investment.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

1
What's At Stake In Latin American Elections In 2018

2018-06-27 seekingalpha
It is a critical year for elections in Latin America (“Latam”), with the three largest countries by population holding major votes before year-end. In an effort to shed more light on the impact of this election cycle, we will write a series of pieces covering the potential impact on local economies and the investment climate. In the table below, we enumerate the concerns and opportunities at stake across the major Latam elections this year.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

1
Digging In To Floating And Variable Rate Preferreds

2018-06-26 seekingalpha
As interest rates have continued to rise, a paramount concern for investors is how this environment will impact the yield and principal of their income-oriented investments. A popular approach is to eschew fixed-rate securities, which tend to have more interest rate sensitivity, in favor of floating or variable rate issues, which may see their coupons rise along with interest rates. In this piece, we look specifically into preferred stock to see if floating rate and fixed-to-floating rate preferreds can potentially mitigate the impact of a rising rate environment.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

1
What's Driving FinTech's Growth?

2018-06-24 seekingalpha
FinTech is emerging as a powerful theme in 2018, driven by the rapid adoption of cutting edge technologies across the financial services industry, such as digital payments and money transfers, financial software and automation, and alternative lending and funding platforms. In this piece, we look at the major trends that are propelling FinTech’s growth, including:
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

52
How To Play All Sides Of The Square Vs. PayPal Battle

2018-06-21 seekingalpha
I'm playing all sides and broadly investing in FinTech through Global X Funds Thematic FinTech ETF (FINX).
DB SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX TWTR CHIX SRET BOTZ SQ CATH GURX GURI ALUM MILN WRCDF CJHIQ URA FISV INTU WCAGY LNGR COPX YRD QQQC GURU

56
MLP Monthly Report: June 2018

2018-06-20 seekingalpha
The June MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
SNSR MLPA AND LIT CVI BFIT KMI.WS GXG SIL KRMA GXF EPD CHII EV ACTX CHIE GOEX KMI.PRA KMI FINX CHIX KMR CVB SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI LNGR COPX CVRR QQQC KRP GURU KMRFZ

1
GURU May 2018 Rebalance Report

2018-06-10 seekingalpha
On May 25th, the Global X GURU Index ETF (NYSEARCA:GURU) underwent its quarterly rebalance. The May 2018 GURU Report can be found here.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

17
MLP Insights: Q2 2018

2018-06-10 seekingalpha
2018 has not stopped the wild ride for MLP investors that began in 2014. The initial euphoria of tax reform earlier in the year abated as the broad equity markets became more volatile. In mid-March as the Federal Energy Regulatory Commission (FERC) rulingdisallowing a previously accepted MLP income tax allowance saw fatigued investors exit the MLP market. While MLPs have recovered by more than 14% since the nadir in late-March,1 a new elephant has entered the room: uncertainty around the future of the MLP structure.
APLP SNSR AND LIT BFIT KMI.WS GXG SIL KRMA GXF CHII TEP SEP ACTX CHIE WPZ GOEX KMI.PRA KMI FINX CHIX EEP KMR CVB SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA TCP LNGR COPX QQQC GURU KMRFZ

130
ESG Funds: Impact And Alpha

2018-06-06 seekingalpha
This article originally appeared in the June issue of Wealth Management magazine and online at Brad Zigler.
SNSR AND TXN LIT KRMA BFIT GXG SIL ADP GXF ESG CHII ACTX CHIE GOEX FINX CHIX 3772 MSCI SRET BOTZ CATH ESGU GURX GURI DSI ALUM MILN CJHIQ URA LNGR ADPVV TROW COPX ABBV QQQC GURU

52
MLP Monthly Report: May 2018

2018-06-05 seekingalpha
The May MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
EEQ SNSR MLPA AND LIT BFIT GXG SIL KRMA GXF CHII MPC ANDV SEP ANDX EV ACTX CHIE WPZ GOEX FINX CHIX EEP SRET MPLX BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI TCP LNGR COPX QQQC CQH GURU

10
Q2 Overview: Where Are We Now?

2018-05-23 seekingalpha
Yes, X marks the spot. But only when you have a good map. The era of easy money fueled by central bank intervention has investors searching for clues about where the market is in this protracted cycle and whether the water we are seeing-the Dow Jones Industrial Average Index is up 1200 points since its 2018 intraday low on May 3-is this an oasis or a mirage. The natural question everyone is asking is, Where are we now? It's a good question.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR WTI COPX QQQC GURU

2
Scientific Beta Factor Report: Q1 2018

2018-05-22 seekingalpha
The Global X research team updated the Scientific Beta Factor Report for Q1 2018, analyzing the performance and characteristics of factors in the US and international markets. The full Q1 Factor Report can be read here.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR DM COPX QQQC GURU

1
Chart: The Nature Of Midstream MLP Debt

2018-05-06 seekingalpha
As the Federal Reserve continues along its path of raising interest rates, many MLP investors have asked how these actions will impact MLPs. We believe there are two key considerations when assessing this question:
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

1
Global X Preferred Report: Q1 2018

2018-05-03 seekingalpha
The Global X research team has posted the Global X Preferred Report for Q1, highlighting yield comparisons, performance, historical distributions, underlying credit ratings, and other preferred equity analytics for the Global X Preferred family. Click here to read the report.
SNSR AND LIT BFIT GXG SIL KRMA GXF CHII ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA LNGR COPX QQQC GURU

30
MLP Monthly Report: April 2018

2018-04-29 seekingalpha
The April MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
SNSR MLPA AND LIT BFIT GXG SIL KRMA GXF CHII TEP TEGP EV ACTX CHIE GOEX FINX CHIX SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI LNGR COPX QQQC GURU

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

15h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

17h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to SIL / Global X Funds on message board site Silicon Investor.

Silicon Investor - New feature discussion Gold and Silver Juniors, Mid-tiers and Producers
Kootenay Silver Silicon Motion Inc. (SIMO)
Silicon Investor - Welcome New SI Members! Silver Bull Resources, Inc.
Clifton Mining (CFB-Alberta)-Silver Play Silver Recovery -- Itronics (ITRO)
HHS.C - Hi Ho Silver Resources Inc. Silicon Investor - User Site Discussion - Generally Unmodera
CUSIP: 37954Y848